HSP90 inhibition without heat shock response

摘要

In this issue of Blood, Bhatia and colleagues describe a heat shock protein 90 (HSP90) C-terminal dimerization inhibitor with mechanistic differences that distinguish it from other clinically unsuccessful N-terminal ATPase binding compounds.(1) Can graveyard raiding of an old therapeutic target with a new strategy bring long awaited success?